What are the long-term side effects of weight loss injections?

Which side effects tend to fade and which ones linger?

The short answer is that the side effects most people experience (nausea, loose stools, constipation, reflux, burping and fatigue) are at their worst in the first few weeks and particularly after each dose increase. The body's response to slowed gastric emptying is largely a settling-in process. By the time patients reach a maintenance dose, many report that the GI disruption has quietened considerably or disappeared.

What is less clear is how bodies respond over periods longer than two years, because that is roughly the outer edge of the current trial data. The SURMOUNT-1 trial for tirzepatide ran to 72 weeks, and the STEP 1 trial for semaglutide to 68 weeks; both showed that the side-effect burden fell as treatment continued rather than accumulating. Post-market surveillance is ongoing, and the MHRA's Yellow Card scheme collects reports from real patients using these medicines beyond trial conditions.

Some effects are worth monitoring over a longer horizon. Muscle mass can decrease alongside fat when weight falls rapidly; clinical guidance consistently recommends adequate protein intake and resistance exercise alongside treatment. Gallbladder symptoms (particularly gallstones) are a recognised risk with significant weight loss by any method, and GLP-1 medicines are no exception. These are not common, but they are worth knowing about. Our guide to side effects of weight loss injections covers the full picture from the first injection onwards.

Are there long-term effects that should prompt urgent medical attention?

Yes, and this section matters. Several effects (though uncommon) can be serious if missed.

Acute pancreatitis is the most important. In January 2026, the MHRA published a Drug Safety Update confirming that GLP-1 medicines carry a known, infrequent risk of acute pancreatitis. The symptom to act on is severe abdominal pain that reaches into the back, with or without vomiting, that does not ease. This is a 999 or A&E situation, not a wait-and-see one.

Gallbladder problems (upper-right abdominal pain, fever, jaundice) also warrant prompt attention. Significant or rapid dehydration from prolonged vomiting or diarrhoea can strain the kidneys; if you cannot keep fluids down for more than a day, contact your GP or 111. Signs of an allergic reaction (swelling of the face or throat, difficulty breathing) need emergency care immediately.

Anyone experiencing low mood, depressive thoughts or thoughts of self-harm should speak to a clinician without delay, these have been reported in post-market surveillance and are taken seriously by regulators. If anything feels wrong and you are unsure whether it is related to treatment, the safest move is always to ask. You can also report any suspected side effect directly through Yellow Card, patients can submit reports themselves, not just healthcare professionals.

What do we know about long-term effects specific to tirzepatide versus semaglutide?

Both medicines share a broadly similar side-effect profile because both slow gastric emptying and act on appetite pathways. Tirzepatide activates both GIP and GLP-1 receptors; semaglutide activates GLP-1 receptors only. In practice, both produce a GI-led side-effect pattern, and neither has long-term safety data extending beyond the clinical trial window of roughly 68 to 72 weeks at the time of writing.

One practical difference the NHS highlights is around oral contraceptives. Women taking tirzepatide should use an additional non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, because the absorption of the pill may be affected. The same concern has not been established for semaglutide. This is not a long-term effect as such, but it is an ongoing consideration throughout treatment. NHS England's guidance on weight-management injections explains this and other practical points clearly.

For a fuller comparison of how these two medicines compare over time, if you are curious about what the long-term effects of weight loss injections actually look like for both semaglutide and tirzepatide side by side, our dedicated overview covers exactly that. Questions about which medicine might suit you are exactly what a prescriber at nume is there to work through with you.

What happens to side effects if you stop treatment?

When GLP-1 treatment stops, the physiological effects reverse over a matter of weeks. Gastric emptying returns to its previous rate, appetite typically increases again, and the GI side effects resolve. There is no evidence that these medicines cause lasting gut damage or a permanent change in how the digestive system works.

The harder clinical question is about weight. Trial data shows that weight tends to return after stopping, which is why our page on weight loss injections long term covers what ongoing treatment involves and why medical guidelines treat obesity as a chronic condition rather than one requiring a fixed course. That is a conversation for your prescriber rather than something to decide based on how you feel on any given day, stopping without clinical discussion is not advisable.

Storage is worth a brief mention here: keeping your pen in the fridge door (between 2 and 8°C) is the standard guidance, though the exact room-temperature window if a pen is out of the fridge varies between products and is set out in the Patient Information Leaflet, not something to estimate. If you want to understand more about what treatment involves from the start, our weight loss injection guide walks through injection basics, and if you are based locally, our page on weight loss injections in Nottingham explains how you can access treatment and support near you, including details on the side effects associated with B12 injections for weight loss. Eligibility and aftercare (including what happens if you want to pause or stop) are part of every consultation at nume.